LB PHARMACEUTICALS INC (LBRX) Operating cash flow 2024–2025
LB PHARMACEUTICALS INC (LBRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35.2MFY2025 · since FY2024: -$53.1M → -$35.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.2M | +33.6% |
| FY2024 | -$53.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LBRX financial trends
LBRX RevenueLBRX Net incomeLBRX Net marginLBRX Gross profitLBRX Gross marginLBRX Operating incomeLBRX Operating marginLBRX Free cash flowLBRX Capital expendituresLBRX Return on equityLBRX Stock buybacksLBRX Dividends paidLBRX Total assetsLBRX Total liabilitiesLBRX Shareholders’ equityLBRX overview →